C-ABL-IN-5, a selective c-Abl inhibitor, exhibits neuroprotective properties and has favorable characteristics including blood-brain barrier permeability, metabolic stability, and pharmacokinetic profiles. When labeled with [18F] (compound [18F]3), C-ABL-IN-5 serves as a tracer in positron emission tomography (PET) scans to assess disease-modifying effects, particularly in research on neurodegenerative conditions like Parkinsons disease (PD) [1].
Molecular Weight:
341.35
Formula:
C19H17F2N3O
Target:
Bcr-Abl
* VAT and and shipping costs not included. Errors and price changes excepted
